Answering TTP

278 posts

Answering TTP  banner
Answering TTP

Answering TTP

@TTPFoundation

Thrombotic Thrombocytopenic Purpura is a rare blood disorder. Awareness is Low | Research is Hope | Early Diagnosis is Key. Together we can find an Answer!

Global شامل ہوئے Eylül 2014
64 فالونگ130 فالوورز
Answering TTP
Answering TTP @TTPFoundation·
Plasma exchange treatment for TTP is frightening, risky and unpredictable. Patient quote: “When having an episode, the biggest fear is that perhaps the treatment won't work - the risk of heart attack, stroke or death is very real.”
Answering TTP  tweet media
English
1
0
2
0
Answering TTP
Answering TTP @TTPFoundation·
Patient quote on plasma exchange: “It is a HUGE deal! Even with solvent-detergent plasma, the chance of reaction is still high, and one worries what might happen with each treatment. In our case, there were many side effects and rarely was there a 'straight-forward' session.”
Answering TTP  tweet media
English
0
0
1
0
Answering TTP
Answering TTP @TTPFoundation·
Patient quote on plasma exchange: “I cannot underscore enough that plasma exchange is a huge deal. Being hospitalized for weeks away from family, and having your entire blood volume passed through a machine and fed back to you combined with strangers’ blood is mind boggling."
Answering TTP  tweet media
English
0
0
1
0
Answering TTP
Answering TTP @TTPFoundation·
If you’re living with TTP, we’d love to hear from you! Researchers are looking at TTP patients’ experiences with healthcare to understand if differences in access to care after a TTP diagnosis impact outcomes. Please consider taking this anonymous survey: redcap.link/TTPstudy
Answering TTP  tweet media
English
0
1
1
0
Answering TTP
Answering TTP @TTPFoundation·
LAST DAY TO COMPLETE THE PATIENT SURVEY! Thank you to those who have submitted your stories in hopes of making caplacizumab accessible in the future for those in need. If you or someone you know has a story to share, please do so today. Survey Link -> shorturl.at/bwGY6
Answering TTP  tweet media
English
0
0
0
0
Answering TTP
Answering TTP @TTPFoundation·
DEADLINE EXTENDED TO June 8th, 2022! With caplacizumab being reviewed again by CADTH, we are seeking Canadian TTP patients and their caregivers to share their experiences to prevent CADTH from getting a second negative recommendation. Share your story: shorturl.at/bwGY6
Answering TTP  tweet media
English
0
0
1
0
Answering TTP
Answering TTP @TTPFoundation·
We are excited that caplacizumab (Cablivi) will be reviewed again by CADTH and need your help! There are only 3 days left for Canadian TTP patients and their caregivers to fill out the survey. Help us make Cablivi accessible for those in need! Survey Link: shorturl.at/bwGY6
Answering TTP  tweet media
English
0
0
2
0
Answering TTP
Answering TTP @TTPFoundation·
5 Days Left! There’s still time to help make caplacizumab (Cablivi) more accessible to patients in need! If you’re a Canadian TTP patient, or a caregiver of a TTP patient, fill out the survey to help CADTH in their secondary review! Survey Link -> shorturl.at/bwGY6
Answering TTP  tweet media
English
0
0
0
0
Answering TTP
Answering TTP @TTPFoundation·
The struggle of living with TTP does not end after receiving treatment- patients live with a range of severe complications post treatment, impacting their lives forever. #ttp #raredisease
Answering TTP  tweet media
English
0
1
2
0
Answering TTP
Answering TTP @TTPFoundation·
TTP has an extremely high mortality rate if left untreated. TTP patients face a constant fear of experiencing a relapse and not being able to receive the immediate treatment they need. #ttp #raredisease
Answering TTP  tweet media
English
0
1
4
0
Jessica Bell
Jessica Bell@JessicaBellTO·
Today I handed MOH @celliottability letters sharing the painful impact #aTTP has on UniRose families, and how timely access to treatment is a matter of life or death for their loved ones. Thank you for meeting with me @_kristinabryant, @andrewjlbryant, David & Barb Firman.
Jessica Bell tweet media
English
1
3
4
0